News Focus
News Focus
icon url

HattieTheWitch

12/23/10 9:02 PM

#111428 RE: DewDiligence #111407

The only downside was running a single trial whose cost was trivial for a company of Teva's size.

Should one assume that the results of that trial will be a) in TEVA's favor, and b) not too long in coming?

Thank you.